PRESCRIPTION PATTERN OF MEDICINES IN CHRONIC KIDNEY DISEASE PATIENTS IN NEPHROLOGY DEPARTMENT OF A TERTIARY CARE TEACHING HOSPITAL: AN OBSERVATIONAL STUDY

Main Article Content

Keywords

Chronic Kidney Disease, Drug Utilization Pattern, Rationality, WHO Core Prescribing Indicators

Abstract

Objectives: Chronic Kidney Disease patients required lifelong multiple therapy. Multitudinous medication increases risk of irrational drug use and drugs related problems in CKD patients. This study was done to estimate the current trends of prescribing pattern of medicines in chronic kidney disease patients and to assess the rationality of prescriptions. Methods: A prospective observational study was conducted at a tertiary care teaching hospital. All the prescribing details of study participants including patient’s demographic details, diagnosis, drug name, dose, duration and frequency were recorded in specially designed performa and rationality of prescription was assessed using WHO core prescribing indicators. Results: Demographic analysis showed males predominance with 54% and females were 46%. Most of the study population belongs to the age group more than 40 years (50%). Anemia and Hypertension were the main co morbidities associated with CKD followed by diabetes. Most commonly prescribed drugs were cardiovascular drugs (18.24%) in which anti-hypertensive i.e. calcium channel blockers (24%) and diuretics (20%) were commonly used. Conclusions: The present study concluded that further improvements are needed in prescribing practices of CKD patients mainly in average number of drugs per prescription, prescription of drugs with generic names and prescription of drugs from the National essential medicines list.

Abstract 160 | Pdf Downloads 90

References

1. Jha V, Wang AY, Wang H. The impact of CKD identification in large countries. The burden of illness. Nephron Dial Transplant 2012;27 Suppl: iii 32-8.
2. Jha VK &Shashibhushan. Clinical Profile of Chronic Kidney Disease Patients in a Tertiary Care Hospital- An Observational Study. J Nephrol Kidney Disease 2018; 2(2) : 1016.
3. Santra S; Agrawal D, Kumar S, Mishra SS. A study on the drug utilization pattern in patients with chronic kidney disese with emphasis on antibiotics. J Integrative Nephrol Androl. 2015 July 1; 2(3) : 85.
4. Ahlawat R, Cruz SD, Tiwari P. Drug utilization pattern in chronic kidney disease patients at a tertiary care public teaching hospital: Evidence from a cross-sectional study. J Pharma Care Health Sys.2015 Dec; 3:149-53.
5. GBD 2015 Disease and Injury Incidence and Prevalence Collaborations, author. Global, regional, and national incidence, prevalence, and years lived with disability for 310 disease and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10053): 1545.
6. Mann J FE, Gerstein HC, DulaxFlorea I, Lonn E. Cardiovascular risk in patients with mild renal unsufficiency kid int. 2003; 63; S1 92-196.
7. “Polypharmacy in Elderly Patients” (PDF). Vumc.nl.Retrieved 16 January 2015.
8. Finkel R; Clark, MA; Cubeddu, LX. Lippincott’s Illustrated Reviews: Pharmacology, 4th edition, 2009; 1.
9. Chakraborty S, Ghosh S, Banerjea A, De RR, Hazra A, Mandal SK. Prescribing patterns of medicines in chronic kidney disease patients on maintenance hemodialysis. Indian J Pharmacol 2016; 48: 586-90.
10. Kishore J. National Health Programs of India. 6th ed. New Delhi: Century Publications; 2006: p.370.
11. WHO. How to investigate drug use in health facilities. Selected drug use indicators. Geneva: World Health Organization; 1993. WHO/DAP 1993; 1:1-87.
12. Ofori-Asenso R. A closer look at the World Health Organization’s Prescribing indicators. J PharmacolPharmacother. 2016;7(1); 51-4.
13. Pradhan SC, Shewade DG, Tekur U, Zutshi S, Pachiappan D, Dey AK, Adithan C, Shashindran CH, Bapna JS. Changing Pattern of antimicrobials utilization in an Indian teaching hospital. Int J Clin PharmacolTherToxicol 1990; 28: 339-43.
14. Soumerai SB. Factors influencing prescribing. Aust J Hosp Pharm 1988 (Suppl); 18: 9-16
15. Giampaolo Pvelo and Pietro Minuz. Medication errors: Prescribing faults and Prescription errors BrJ Clin Pharmacol. 2009 Jun; 67(6): 624-628.
16. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAM A. 1997;27: 312-7.
17. Dean B, Vincent C, Schachter M, Barber N. The incidence of prescribing errors in hospital in patients: an overview of the research methods. Drug Saf. 2005; 28: 891-900.
18. Introduction to Drug utilization research. Oslo: World Health Organization; m2003. Chapter 1, what is drug utilization research and why it is needed? P.8-12.
19. Laporte JR, Orme ML. Drug utilization and the teaching of rational drug use. WHO Reg Publ Eur. 1993;45:183-91.
20. Bajait CS, Pimpalkhute SA, Sontakke SD, Jaiswal KM, Dawri AV. Prescribing pattern of medicine in chronic kidney disease with emphasis on phosphate binders. Indian J Pharmacol.2014;46:35-9..
21. “Essential medicines.” World Health Organization (WHO), Retrieved 20 January 2017.